Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Canterbury Park Holding Corporation reported a 3.2% increase in net revenues to $16.2 million for Q2 2026 and a 29.3% increase in adjusted EBITDA to $2.6 million, reflecting growth across Casino, Pari-mutuel, and Food and Beverage operations. Despite a net loss due to an impairment charge linked to prior horserace purse overpayments, the company sh…
Kyverna Therapeutics reported Q2 2026 financial results and significant clinical and regulatory progress for its lead CAR T-cell therapy candidate, miv-cel, targeting neurologic autoimmune diseases. The FDA granted RMAT designation for miv-cel in non-active secondary progressive multiple sclerosis, highlighting promising clinical data. The company …
Erasca, Inc. announced encouraging updated clinical data for its ERAS-0015 candidate showing promising efficacy and tolerability in KRAS G12X pancreatic and lung cancers. The company raised $632 million in a recent upsized public offering to advance multiple registration-enabling trials and strengthen its balance sheet. Several key clinical milesto…
Maze Therapeutics announced its Q2 2026 financial results alongside clinical updates on its Phase 2 programs targeting APOL1-mediated kidney disease and phenylketonuria. Enrollment in multiple Phase 2 trials is progressing on schedule, with important data expected in late 2026 and 2027. The company holds a strong cash position of nearly $495 millio…
Aquestive Therapeutics reported a Q2 2026 revenue increase driven by manufacturing and royalties and reaffirmed plans to resubmit its Anaphylm (dibutepinephrine) NDA to the FDA in Q3 2026 following successful human factors and pharmacokinetic studies. The company continues to advance its epinephrine AdrenaVerse platform, including AQST-108 for derm…
Leonardo DRS demonstrated that its SGT STOUT M-SHORAD Mission Equipment Package can effectively defeat smaller Group 1-2 unmanned aerial systems through software updates without hardware changes, highlighting its modular and upgradeable architecture. This marks a significant advancement in scalable, modern air defense capabilities, emphasizing rapi…
Belite Bio announced FDA acceptance and Priority Review of its New Drug Application for tinlarebant, a novel oral therapy intended to treat Stargardt Disease Type 1 (STGD1), a rare inherited retinal disease. The NDA submission is supported by positive Phase 3 DRAGON trial results demonstrating a 35.7% reduction in atrophic retinal lesion growth rat…
Inhibikase Therapeutics announced its Q2 2026 financial results, highlighting significant progress in its Phase 3 IMPROVE-PAH clinical trial for IKT-001, a novel oral treatment for Pulmonary Arterial Hypertension (PAH). The company secured regulatory approvals in 26 countries, initiated 43 clinical sites globally, and obtained Orphan Drug Designati…
Taysha Gene Therapies reported Q2 2026 financial results and corporate updates including completed dosing in its pivotal REVEAL and ASPIRE trials for TSHA-102 gene therapy targeting Rett syndrome. The therapy showed a favorable safety profile and promising longer-term functional benefits. The company has advanced commercial and manufacturing readin…
Xcel Brands, a media and consumer products company, announced it will report its Q2 2026 financial results on August 13, 2026, followed by an earnings call on August 14. The company focuses on branded apparel, accessories, and social commerce, owning several lifestyle brands and utilizing diverse sales channels including live streaming and interact…
Lyft is not the global behemoth Uber is, but it has carved an economically viable niche in North America. With free cash flow of roughly $1.12B, a market cap near $7.0B and a P/E around 2.3, Lyft looks attractively priced for a mid-term tactical long. Trade plan: enter $17.55, stop $15.00, target $22.00 over a mid term (45 trading days).
Northrop Grumman has revealed Raid Hunter, a 50mm gun-centered air defense solution built to protect installations from cruise missiles, drone swarms and similar aerial threats. The system pairs Chain Gun mechanics, precision-guided 50mm rounds and a networked controller to deliver sustained, rapid fire from deep magazines. Designed for rapid movem…
This week two Mexican energy-related issuers requested regulatory clearances for capital market transactions spanning domestic and international markets. Esentia Energy Development confidentially updated its share registration to permit a potential mixed global stock offering, including American Depository Shares in foreign markets. CFECapital, man…
Norway’s $2.3 trillion sovereign wealth fund reported owning a 0.05% stake in SpaceX valued at $1.22 billion on June 30, according to an updated holdings list. The position is a comparatively small part of the fund’s technology exposure within a portfolio that spans roughly 7,200 companies and includes allocations to property and renewable energy.
Chicago Board of Trade soybean futures fell on Tuesday as market participants adjusted positions ahead of a U.S. Department of Agriculture supply and demand report due Wednesday. Analysts noted recent rainfall and cooler temperatures have aided recovery of the U.S. Midwest soybean crop after July's heat and dryness. A Reuters survey expects the USD…
Fixed-income strategists polled in early August continue to project a decline in U.S. Treasury yields over the next 12 months, forecasting the 10-year to fall from near 4.73% to about 4.34% in a year. However, most respondents say it is more likely actual yields will come in higher than their three-month forecasts, reflecting persistent inflation c…
The U.S. Energy Information Administration warns that several Middle East producers are unlikely to restore production to pre-conflict volumes by the end of 2027, even if trade patterns begin normalizing early next year. Significant shut-ins, constrained flows through the Strait of Hormuz and a widening supply deficit have forced the agency to revi…
Kodiak Gas Services (KGS) combines fixed-revenue contract compression with expanding distributed power opportunities tied to AI and edge power demand. The company trades at about $61.05 with a $6.54B market cap, EV/EBITDA of ~12.9 and annual free cash flow of roughly $200M. We outline a long trade with clear entry, stop and target, plus the catalys…
Meta Platforms ($META) looks oversold relative to its fundamentals. The company generates roughly $41B in free cash flow, sports a 26% return on equity, and trades at ~22x earnings - not nosebleed for a company executing AI and ad monetization plays. This trade targets a mean-reversion and sentiment rebound into AI spending updates and ad cadence o…
Guardant Health is the leading pure-play liquid biopsy name. Recent FDA expansion for Guardant360 Liquid CDx, strong technicals, and large market projections for cancer biomarkers create a clear growth narrative. This trade idea outlines a long position with precise entry, stop and target, while laying out catalysts, valuation context and risks tie…
New Era Energy & Digital, a U.S.-based developer of digital infrastructure and integrated power assets, announced it will file its Q2 2026 financial results on August 14, 2026, followed by a business update call on August 17. The company focuses on large-scale data centers powered by flexible energy solutions, primarily serving AI computing needs.
Anterix issued a statement endorsing SpaceX's recent FCC filing proposing technology-neutral buildout options for broadband licenses in the 896-901/935-940 MHz band. This support highlights growing interest and potential accelerated utilization of low band spectrum, which is crucial for private wireless broadband and critical infrastructure communi…
Nvidia's latest large acquisition meaningfully expands its addressable AI stack and strengthens its moat in data-center AI. We upgrade to a constructive rating and offer a long trade designed to capture post-deal integration upside while managing valuation risk.
Hiroshi Okuda, who led Toyota Motor Corp. through a major phase of global manufacturing expansion and strategic change in the late 1990s and early 2000s, has died at age 93. Okuda, a lifelong Toyota employee who rose from accounting to the company’s top posts, steered the automaker toward broader international production and supported the launch of…
CN closed the 2025-26 crop year by moving a record 33.8 million metric tonnes of grain from Western Canada, surpassing the previous year's record. This achievement reflects strong customer demand and effective execution of CN's operational plan. The company is focused on maintaining reliable service and has released its 2026-27 Grain Plan to suppor…
